A rosuvastatin-loaded immunomodulatory hydrogel improves stem cell therapy for cardiac repair by mitigating local immune responses against transplanted cells and promoting heart repair.
Does a rosuvastatin-loaded injectable immunomodulatory hydrogel improve the effectiveness of stem cell therapy for cardiac repair in an in vivo infarcted heart model?
A rosuvastatin-loaded injectable hydrogel may improve the efficacy of stem cell therapy for myocardial infarction by modulating the local immune response.
Absolute Event Rate: 0% vs 0%
polarization in response to inflammatory stress in the infarcted heart. Therefore, the current study presents a new paradigm in improving clinical effectiveness of stem cell therapy for cardiac repair by modulating local immune response in the heart against transplanted stem cells using a novel immunomodulatory CR hydrogel.
Yan et al. (Fri,) reported a other. A rosuvastatin-loaded immunomodulatory hydrogel improves stem cell therapy for cardiac repair by mitigating local immune responses against transplanted cells and promoting heart repair.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: